(MSHL, CSIQ, SLXP, PGNX) CRWENewswire Stocks In Action
- 2011/12/21 05:56:53 投稿
- 再生数：16
- マイリスト数：0
Salix Pharmaceuticals Ltd - SLXP - and Progenics Pharmaceuticals Inc - PGNX - reported the successful outcome of the Phase 3 trial to evaluate the efficacy and safety of oral methylnaltrexone for the treatment of opioid-induced constipation in subjects with chronic, non-cancer pa